BindingDB logo
myBDB logout

null

SMILES: CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)c1nn[nH]n1

InChI Key: InChIKey=SCCRXLRICSMLTR-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 455225   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Plasma kallikrein


(Homo sapiens (Human))
BDBM455225
PNG
(US10730874, Compound I-238 | US11352356, Compound ...)
Show SMILES CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)c1nn[nH]n1
Show InChI InChI=1S/C28H27ClFN11O/c1-28(2,27-35-37-38-36-27)8-17-7-18(16-3-4-16)11-40-13-20(34-25(17)40)14-41-12-19(9-33-41)26(42)31-10-22-24-23(30)21(29)5-6-39(24)15-32-22/h5-7,9,11-13,15-16H,3-4,8,10,14H2,1-2H3,(H,31,42)(H,35,36,37,38)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a


TBA

Assay Description
Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2W95DCK
More data for this
Ligand-Target Pair
Plasma kallikrein


(Homo sapiens (Human))
BDBM455225
PNG
(US10730874, Compound I-238 | US11352356, Compound ...)
Show SMILES CC(C)(Cc1cc(cn2cc(Cn3cc(cn3)C(=O)NCc3ncn4ccc(Cl)c(F)c34)nc12)C1CC1)c1nn[nH]n1
Show InChI InChI=1S/C28H27ClFN11O/c1-28(2,27-35-37-38-36-27)8-17-7-18(16-3-4-16)11-40-13-20(34-25(17)40)14-41-12-19(9-33-41)26(42)31-10-22-24-23(30)21(29)5-6-39(24)15-32-22/h5-7,9,11-13,15-16H,3-4,8,10,14H2,1-2H3,(H,31,42)(H,35,36,37,38)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<1n/an/an/an/a



Shire Human Genetic Therapies, Inc.

US Patent


Assay Description
Example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing a fluorogenic peptide s...


US Patent US10730874 (2020)


BindingDB Entry DOI: 10.7270/Q2RN3BXC
More data for this
Ligand-Target Pair